Verfahren zur Diagnose oder Prädiagnose einer Beta-Amyloidopathie
European patent · EP2693216 · In force
Register entry
- Publication number
- EP2693216
- Application number
- EP13190419
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 30, 2011
- Published
- Feb 5, 2014
- Granted
- Sep 12, 2018
- Protection ends at the latest
- Aug 29, 2031
- Next annual fee due
- Aug 31, 2027
- IPC classes
- G01N 33/68 (2006.01)
- Priority
- DE 102010044561 07.09.2010
- Filing language
- German
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
- Sep 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.08.2025 → 31.08.2026
Published in Swissreg on 01.09.2025
- Sep 1, 2024
Next annual fee due on
- Next annual fee due on
- 31.08.2024 → 31.08.2025
Published in Swissreg on 01.09.2024
- Sep 1, 2023
Change
Published in Swissreg on 01.09.2023
- Sep 1, 2022
Change
Published in Swissreg on 01.09.2022
- Dec 19, 2018
Agent entered
- Representative
- Schmauder & Partner AG, Patent- und Markenanwälte VSP, Zwängiweg 7, 8038 Zürich
Published in Swissreg on 19.12.2018
- Sep 12, 2018
Granted
Published in Swissreg on 12.09.2018
Parties
Agent
Inventor
Pahnke, Jens
39104 Magdeburg, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.